Literature DB >> 19344228

Obstructive sleep apnea, inflammation, and the metabolic syndrome.

Andrew D Calvin1, Felipe N Albuquerque, Francisco Lopez-Jimenez, Virend K Somers.   

Abstract

The combination of metabolic syndrome and obstructive sleep apnea (OSA) has been termed "syndrome Z." The prevalence of both OSA and metabolic syndrome is increasing worldwide, in part linked to the epidemic of obesity. Beyond their epidemiologic relationship, growing evidence suggests that OSA may be causally related to metabolic syndrome. We are only beginning to understand the potential mechanisms underlying the OSA-metabolic syndrome interaction. Although there is no clear consensus, there is growing evidence that alterations in the hypothalamic-pituitary axis, generation of reactive oxygen species (ROS) due to repetitive hypoxia, inflammation, and generation of adipokines may be implicated in the changes associated with both OSA and metabolic syndrome. Whether some or all of these metabolic alterations mechanistically link OSA to metabolic syndrome remains to be proven, but it is an area of intense scientific interest.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19344228      PMCID: PMC3135895          DOI: 10.1089/met.2008.0093

Source DB:  PubMed          Journal:  Metab Syndr Relat Disord        ISSN: 1540-4196            Impact factor:   1.894


  115 in total

Review 1.  Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force.

Authors: 
Journal:  Sleep       Date:  1999-08-01       Impact factor: 5.849

Review 2.  Pharmaco-redox regulation of cytokine-related pathways: from receptor signaling to pharmacogenomics.

Authors:  John J Haddad
Journal:  Free Radic Biol Med       Date:  2002-10-01       Impact factor: 7.376

3.  Relation of habitual snoring with components of metabolic syndrome in Korean adults.

Authors:  Namhan Cho; SoonJae Joo; JinKwan Kim; Robert D Abbott; JeHyeong Kim; Kuchan Kimm; Chol Shin
Journal:  Diabetes Res Clin Pract       Date:  2005-08-19       Impact factor: 5.602

Review 4.  Oxidative stress-induced risk factors associated with the metabolic syndrome: a unifying hypothesis.

Authors:  Ignazio Grattagliano; Vincenzo O Palmieri; Piero Portincasa; Antonio Moschetta; Giuseppe Palasciano
Journal:  J Nutr Biochem       Date:  2007-09-12       Impact factor: 6.048

5.  Muscle fiber area distribution of musculus uvulae in obstructive sleep apnea and non-apneic snorers.

Authors:  F Sériès; J A Simoneau; S St Pierre
Journal:  Int J Obes Relat Metab Disord       Date:  2000-04

Review 6.  The metabolic syndrome.

Authors:  Robert H Eckel; Scott M Grundy; Paul Z Zimmet
Journal:  Lancet       Date:  2005 Apr 16-22       Impact factor: 79.321

7.  Reduced levels of adiponectin in sleep apnea syndrome.

Authors:  B Masserini; P S Morpurgo; F Donadio; C Baldessari; R Bossi; P Beck-Peccoz; E Orsi
Journal:  J Endocrinol Invest       Date:  2006-09       Impact factor: 4.256

8.  The role of habitual snoring and obesity in the development of diabetes: a 10-year follow-up study in a male population.

Authors:  A Elmasry; C Janson; E Lindberg; T Gislason; M A Tageldin; G Boman
Journal:  J Intern Med       Date:  2000-07       Impact factor: 8.989

9.  The severity of obstructive sleep apnoea is associated with insulin resistance.

Authors: 
Journal:  J Sleep Res       Date:  1993-03       Impact factor: 3.981

10.  Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk.

Authors:  Hans K Meier-Ewert; Paul M Ridker; Nader Rifai; Meredith M Regan; Nick J Price; David F Dinges; Janet M Mullington
Journal:  J Am Coll Cardiol       Date:  2004-02-18       Impact factor: 24.094

View more
  37 in total

1.  APAP impact on metabolic syndrome in obstructive sleep apnea patients.

Authors:  Patrícia Caetano Mota; Marta Drummond; João Carlos Winck; Ana Cristina Santos; João Almeida; José Agostinho Marques
Journal:  Sleep Breath       Date:  2010-09-24       Impact factor: 2.816

2.  Interaction between Obstructive Sleep Apnea and Shortened Telomere Length on Brain White Matter Abnormality.

Authors:  Kyung-Mee Choi; Robert J Thomas; Dai Wui Yoon; Seung Ku Lee; Inkyung Baik; Chol Shin
Journal:  Sleep       Date:  2016-09-01       Impact factor: 5.849

3.  High prevalence of peripheral arterial disease in patients with obstructive sleep apnoea.

Authors:  C A Schaefer; L Adam; J Weisser-Thomas; S Pingel; G Vogel; U Klarmann-Schulz; G Nickenig; C Pizarro; D Skowasch
Journal:  Clin Res Cardiol       Date:  2015-03-01       Impact factor: 5.460

4.  Sleep duration and sleep-disordered breathing and the risk of melanoma among US women and men.

Authors:  Jeffrey M Cohen; Yunhui T Li; Shaowei Wu; Jiali Han; Abrar A Qureshi; Eunyoung Cho
Journal:  Int J Dermatol       Date:  2015-08-14       Impact factor: 2.736

5.  Sleep apnea in relation to metabolism: An urgent need to study underlying mechanisms and to develop novel treatments for this unmet clinical need.

Authors:  Olivia M Farr; Christos S Mantzoros
Journal:  Metabolism       Date:  2017-02-01       Impact factor: 8.694

6.  Drowsiness/alertness algorithm development and validation using synchronized EEG and cognitive performance to individualize a generalized model.

Authors:  Robin R Johnson; Djordje P Popovic; Richard E Olmstead; Maja Stikic; Daniel J Levendowski; Chris Berka
Journal:  Biol Psychol       Date:  2011-03-17       Impact factor: 3.251

Review 7.  The systemic nature of CKD.

Authors:  Carmine Zoccali; Raymond Vanholder; Ziad A Massy; Alberto Ortiz; Pantelis Sarafidis; Friedo W Dekker; Danilo Fliser; Denis Fouque; Gunnar H Heine; Kitty J Jager; Mehmet Kanbay; Francesca Mallamaci; Gianfranco Parati; Patrick Rossignol; Andrzej Wiecek; Gerard London
Journal:  Nat Rev Nephrol       Date:  2017-04-24       Impact factor: 28.314

8.  The effect of sleep apnea and insomnia on blood levels of leptin, insulin resistance, IP-10, and hydrogen sulfide in type 2 diabetic patients.

Authors:  Sushil K Jain; Gunjan Kahlon; Lester Morehead; Benjamin Lieblong; Tommie Stapleton; Robert Hoeldtke; Pat Farrington Bass; Steven N Levine
Journal:  Metab Syndr Relat Disord       Date:  2012-06-29       Impact factor: 1.894

9.  Fractalkine in obstructive sleep apnea patients.

Authors:  Gulgun Cetintas Afsar; Ozlem Oruc; Sema Sarac; Özgür Bilgin Topçuoğlu; Cuneyt Salturk; Fatma Merve Tepetam; Ismet Bulut
Journal:  Sleep Breath       Date:  2016-10-17       Impact factor: 2.816

10.  Serum from obstructive sleep apnea patients induces inflammatory responses in coronary artery endothelial cells.

Authors:  Katherine E Zychowski; Bethany Sanchez; Rodrigo P Pedrosa; Geraldo Lorenzi-Filho; Luciano F Drager; Vsevolod Y Polotsky; Matthew J Campen
Journal:  Atherosclerosis       Date:  2016-09-22       Impact factor: 5.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.